Skip to main content
Fig. 2 | Trials

Fig. 2

From: Resistance training and clinical status in patients with postdischarge symptoms after COVID-19: protocol for a randomized controlled crossover trial “The EXER-COVID Crossover Study”

Fig. 2

Flow of subjects through the “EXER-COVID Crossover Study”. Participants will be first randomly assigned to a 6-week period of no-exercise training (Sequence 1, n=50) or exercise training (Sequence 2, n=50) after which full crossover occurred. T: time-point; PROMs: patient-reported outcome measures; REE: resting energy expenditure; HRV: heart rate variability; BP: blood pressure

Back to article page

Trials

ISSN: 1745-6215